Publication:
Association of Lipid Profile and Body Mass Index with Periodontal Status in Patients with Dyslipidemia with and without Lipid-lowering Medication: A Cross-sectional Study

dc.contributor.authorTechatanawat S.
dc.contributor.authorKomchornrit A.
dc.date.accessioned2022-03-10T13:17:22Z
dc.date.available2022-03-10T13:17:22Z
dc.date.issued2021
dc.date.issuedBE2564
dc.description.abstractPurpose: To investigate the relationship between periodontal parameters and lipid profiles. Subjects and Methods: A total of 48 subjects with dyslipidemia, consisting of 33 subjects who did not receive lipid-lowering medication (NLM) and 15 subjects who did receive lipid-lowering medication (LM) were enrolled in this cross-sectional study. Sixteen systemically healthy subjects were recruited as controls. The plaque index (PI), gingival index (GI), bleeding on probing (BOP), probing depth (PD), and clinical attachment level (CAL) were measured. The levels of triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels were determined. The variables related to high cholesterol levels, including age, gender, waist circumference, and body mass index (BMI), were evaluated. Results: The LM group had a statistically significantly higher CAL in comparison with either the control or the NLM groups. TG was statistically significantly correlated with PD (ρ = 0.398, p = 0.001) and CAL (ρ = 0.349, p = 0.005). HDL-C was negatively correlated with PI (ρ = -0.371, ρ = 0.003), GI (ρ = -0.284, p = 0.025), and PD (ρ = -0.289, p = 0.023). The stepwise multiple regression analysis showed that BMI was statistically significantly associated with percentage of sites with BOP (β = 0.367, p= 0.003) and PD (β = 0.392, p= 0.002). CAL was statistically significantly influenced by age (β = 0.496, p < 0.001) and HDL-C (β = -0.259, p = 0.026). Conclusion: TG and HDL-C levels were correlated with periodontal status. BMI was found to be a stronger predictor of periodontal inflammation than serum lipid levels. No benefit of lipid-lowering medication on periodontal status was revealed. © 2021. All Rights Reserved.
dc.format.mimetypeapplication/pdf
dc.identifier.citationOral Health and Preventive Dentistry. Vol 19, No. (2021), p.149-156
dc.identifier.doi10.3290/j.ohpd.b966783
dc.identifier.issn16021622
dc.identifier.other2-s2.0-85101675575
dc.identifier.urihttps://hdl.handle.net/20.500.14740/8106
dc.language.isoeng
dc.rights.holderScopus
dc.subject.otherCholesterol
dc.subject.otherHigh density lipoprotein cholesterol
dc.subject.otherLipid
dc.subject.otherBody mass
dc.subject.otherCross-sectional study
dc.subject.otherDyslipidemia
dc.subject.otherHuman
dc.subject.otherHyperlipidemia
dc.subject.otherPlaque index
dc.subject.otherBody Mass Index
dc.subject.otherCholesterol
dc.subject.otherCholesterol, HDL
dc.subject.otherCross-Sectional Studies
dc.subject.otherDental Plaque Index
dc.subject.otherDyslipidemias
dc.subject.otherHumans
dc.subject.otherHyperlipidemias
dc.subject.otherLipids
dc.titleAssociation of Lipid Profile and Body Mass Index with Periodontal Status in Patients with Dyslipidemia with and without Lipid-lowering Medication: A Cross-sectional Study
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85101675575&doi=10.3290%2fj.ohpd.b966783&partnerID=40&md5=dd50e43fbe1391de3ee6e470e13a1497

Files